Optimizing The Management of Type 2 Diabetes Mellitus: Integrating Injectable Anti-diabetes Therapies into Clinical Care

Target Audience

Primary care and endocrinology physicians, physician assistants, nurse practitioner, nurses, and other healthcare providers who participate in the management of patients with T2DM. No prerequisites required.

Goal

The goals of this activity are to provide guidance about the clinical use of newer injectable therapies manage patients with T2DM and to offer an opportunity for clinicians to improve their skills in patient evaluation and therapeutic implementation of treatment programs, leveraging multidisciplinary treatment support, utilizing these newer pharmacotherapeutic options.

Learning Objectives

Upon completion of this activity, participants should be able to:

DESCRIBE the pathophysiology and progression of T2DM as it relates to the eventual need for injectable therapies to manage blood glucose.
IDENTIFY provider and patient-derived barriers that contribute to clinical inertia regarding the initiation and intensification of injectable therapy in T2DM.
COMPARE the efficacy, safety, and clinical indications of basal insulin, injected and evolving oral GLP1-RAs, and GLP1-RA/insulin FRCs+ as part of T2DM treatment.
RECOGNIZE clinical scenarios in which progression to an injectable anti-diabetes therapy may be appropriate.
INCORPORATE shared decision-making strategies to facilitate the appropriate utilization of injectable therapies as part of overall T2DM management.